These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7709991)
1. Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies. Faurschou P; Engel AM; Haanaes OC Allergy; 1994 Dec; 49(10):827-32. PubMed ID: 7709991 [TBL] [Abstract][Full Text] [Related]
2. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [TBL] [Abstract][Full Text] [Related]
4. Addition of inhaled salmeterol to inhaled corticosteroids in patients with poorly controlled nocturnal asthma. Norhaya MR; Yap TM; Zainudin BM Respirology; 1999 Mar; 4(1):77-81. PubMed ID: 10339734 [TBL] [Abstract][Full Text] [Related]
5. A one-week dose-ranging study of inhaled salmeterol in children with asthma. Weinstein S; Chervinsky P; Pollard SJ; Bronsky EA; Nathan RA; Prenner B; Howland WC; Stahl E; Liddle R J Asthma; 1997; 34(1):43-52. PubMed ID: 9033439 [TBL] [Abstract][Full Text] [Related]
6. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. Fitzpatrick MF; Mackay T; Driver H; Douglas NJ BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220 [TBL] [Abstract][Full Text] [Related]
7. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. van Noord JA; Schreurs AJ; Mol SJ; Mulder PG Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895 [TBL] [Abstract][Full Text] [Related]
8. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study. Boulet LP; Laviolette M; Boucher S; Knight A; Hébert J; Chapman KR J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):13-21. PubMed ID: 9003206 [TBL] [Abstract][Full Text] [Related]
9. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma. Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285 [TBL] [Abstract][Full Text] [Related]
10. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol. Taylor DR; Town GI; Herbison GP; Boothman-Burrell D; Flannery EM; Hancox B; Harré E; Laubscher K; Linscott V; Ramsay CM; Richards G Thorax; 1998 Sep; 53(9):744-52. PubMed ID: 10319056 [TBL] [Abstract][Full Text] [Related]
11. Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group. Faurschou P; Steffensen I; Jacques L Eur Respir J; 1996 Sep; 9(9):1885-90. PubMed ID: 8880107 [TBL] [Abstract][Full Text] [Related]
12. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma. Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544 [TBL] [Abstract][Full Text] [Related]
13. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Grove A; Lipworth BJ Lancet; 1995 Jul; 346(8969):201-6. PubMed ID: 7616798 [TBL] [Abstract][Full Text] [Related]
14. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily]. Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083 [TBL] [Abstract][Full Text] [Related]
15. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of salmeterol and formoterol in patients with severe asthma. Nightingale JA; Rogers DF; Barnes PJ Chest; 2002 May; 121(5):1401-6. PubMed ID: 12006420 [TBL] [Abstract][Full Text] [Related]
17. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. Britton MG; Earnshaw JS; Palmer JB Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. Ulrik CS Thorax; 1995 Jul; 50(7):750-4. PubMed ID: 7570409 [TBL] [Abstract][Full Text] [Related]
19. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group. Kemp JP; Cook DA; Incaudo GA; Corren J; Kalberg C; Emmett A; Cox FM; Rickard K J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):188-95. PubMed ID: 9500751 [TBL] [Abstract][Full Text] [Related]
20. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]